Attention deficit hyperactivity disorder (ADHD) and substance use disorders
Abstract
Attention deficit hyperactivity disorder (ADHD) is a common childhood disorder that often continues to manifest symptoms into adulthood. In children and adults, this condition may contribute to addictive vulnerability. Several factors are common to the developmental psychopathology of these conditions, suggesting an underlying deficit in behavioral regulation as an explanation for this comorbidity. Developmentally, faulty learning processes or attempts to self-medicate dysfunctional behavior may contribute to the pathogenesis of substance use disorders. Substance abuse itself also may contribute to the development of attentional deficits and behavioral dysregulation through direct (eg, prenatal or self-inflicted exposures to neurotoxic substances) and indirect (eg, poverty, neglect, abuse) mechanisms. Because ADHD can be identified prior to the peak onset of substance use, effective treatment of this common disorder may reduce the development of substance use disorders. Adult ADHD may also contribute to the development and maintenance of substance use disorders Substance abuse patients may particularly benefit from treatment of this comorbidity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The literature supports the view that stimulant treatment for ADHD either has no impact on risk for substance abuse, or may even lower the risk of substance abuse by reducing the early onset of substance abuse in adolescents.
“Despite concerns that pharmacotherapy with stimulant medication may be a risk factor for substance abuse, the literature supports the view that stimulant treatment for ADHD either has no impact in risk for substance abuse, or may even lower the risk of substance abuse by reducing the early onset of substance abuse in adolescents [206,254,257-259].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [206]
Methylphenidate does not lead to stimulant or drug addictions.
“Importantly, both clinical studies and clinical experience support the view that the methylphenidate does not lead to stimulant or drug addictions.”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [206]
Methylphenidate has a neutral or reducing impact on substance abuse and the risk of relapse.
“On the contrary, it has been shown to have a neutral or reducing impact on substance abuse and the risk of relapse [206,253,254].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [206]
The citation lists haven’t been fetched yet
References 83 · Cited by 45
- Authors
- Wilson, J. J., & Levin, F. R.
- Affiliations
- New York State Psychiatric Institute (US)
- ORCID
- Levin, Frances R.
- Venue
- Current Psychiatry Reports
- Published
- 2001-11
- Volume
- 3
- Issue
- 6
- Pages
- 497-506
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- OpenAlex
- W2089352558
- Cited by
- 45
- References
- 83
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2016: 3 · 2014: 3 · 2013: 2 · 2012: 5
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- attention deficit hyperactivity disorder, substance use disorders, comorbidities, adult ADHD, behavioral regulation, self-medication, developmental psychopathology, ADHD treatment
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Psychotherapy, Comorbidity, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review